An Electrocardiogram Study to Evaluate the Effect of Vanzacaftor on the QT/QTc Interval in Healthy Participants

Condition:   Cystic Fibrosis Interventions:   Drug: Vanzacaftor;   Drug: Vanzacaftor Placebo;   Drug: Moxifloxacin;   Drug: Moxifloxacin Placebo Sponsor:   Vertex Pharmaceuticals Incorporated Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials